Imagen de Portada
Código QR

Being Vigilant in Supplier Oversight: Risk assessments, audits, and good communication between sponsor and supplier are key elements of supplier oversight.

Publicado en:Pharmaceutical Technology Europe Vol. 33; no. 4; pp. 33 - 36
Autor principal: Haigney, Susan
Formato: Journal Article
Publicado: MJH Life Sciences Apr2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=142709549&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 142709549
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        17537967
        5NG
      jtl: Pharmaceutical Technology Europe
      issn: 17537967
      maglogo: N
    pubinfo:
      dt: Apr2020
      vid: 33
      iid: 4
      pid: 54670
      pub: MJH Life Sciences
      place: Cranbury, New Jersey
    artinfo:
      ui:
        142709549
        142709549
      ppf: 33
      ppct: 3
      formats:
        fmt:
          @attributes:
            type: P
      tig:
        atl: Being Vigilant in Supplier Oversight: Risk assessments, audits, and good communication between sponsor and supplier are key elements of supplier oversight.
      aug:
        au: Haigney, Susan
      sug:
      pubtype: Trade Publication
      doctype: Journal Article
      ougenre: Article
      ab:
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N